SEARCH

SEARCH BY CITATION

References

  • Althaus H. H. and Richter-Landsberg C. (2000) Glial cells as targets and producers of neurotrophins. Int. Rev. Cytol. 197, 203277.
  • Andersen J. M. and Dietschy J. M. (1979) Absolute rates of cholesterol synthesis in extrahepatic tissues measured with 3H-labeled water and 14C-labeled substrates. J. Lipid Res. 20, 740752.
  • Arnett H. A., Mason J., Marino M., Suzuki K., Matsushima G. K. and Ting J. P.-Y. (2001) TNFα promotes proliferation of oligodendrocyte progenitors and remyelination through TNFR2. Nat. Neurosci. 4, 17.
  • Belknap W. M. and Dietschy J. M. (1988) Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development. J. Clin. Invest. 82, 20772085.
  • Blakemore W. F. (1973a) Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J. Neurol. Sci. 20, 6372.
  • Blakemore W. F. (1973b) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J. Neurol. Sci. 20, 7383.
  • Campagnoni A. T. and Skoff R. P. (2001) The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol. 11, 7491.
  • Carey E. M. and Freeman N. M. (1983) Biochemical changes in cuprizone-induced spongiform encephalopathy. I. Changes in the activities of 2′,3′-cyclic nucleotide 3′-phosphohydrolase, oligodendroglial ceramide galactosyl transferase, and the hydrolysis of the alkenyl group of alkenyl, acyl-glycerophospholipids by plasmalogenase in different regions of the brain. Neurochem. Res. 8, 10291044.
  • Cross M., Mangelsdorf I., Wedel A. and Renkawitz R. (1988) Mouse lysozyme M gene: isolation, characterization, and expression studies. Proc. Natl Acad. Sci. USA 17, 62326236.
  • Dietschy J. M. and Spady D. K. (1984) Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 25, 14691476.
  • Frost D. O. (2001) BDNF/trkB signaling in the developmental sculpting of visual connections. Prog. Brain Res. 134, 3549.
  • Gao Y., Li M., Chen W. and Simons M. (2000) Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J. Cell Physiol. 184, 373379.DOI: 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.3.CO;2-9
  • Gould R. M., Freund C. M., Palmer F. and Feinstein D. L. (2000) Messenger RNAs located in myelin sheath assembly sites. J. Neurochem. 75, 18341844.
  • Hinks G. L. and Franklin R. J. (1999) Distinctive patterns of PDGF-A, FGF-2, IGF-1, and TGF-beta 1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol. Cell. Neurosci. 14, 153168.
  • Hiremath M. M., Saitl Y., Knapp G. W., Ting J. P.-Y., Suzuki K. and Matsushima G. K. (1998) Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 92, 3849.
  • Jadayel D. M., Osborne L. R., Coignet L. J., Zani V. J., Tsui L. C., Scherer S. W. and Dyer M. J. (1998) The BCL7 gene family: deletion of BCL7B in Williams syndrome. Gene 224, 3544.
  • Johns T. G. and Bernard C. C. (1999) The structure and function of myelin oligodendrocyte glycoprotein. J. Neurochem. 72, 19.
  • Jones D., Morgan C. and Cockcroft S. (1999) Phospholipase D and membrane traffic. Potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim. Biophys. Acta 1439, 229244.
  • Jurevics H. and Morell P. (1994) Sources of cholesterol for kidney and nerve during development. J. Lipid Res. 35, 112120.
  • Jurevics H., Hostettler J., Muse E. D., Sammond D. W., Matsushima G. K., Toews A. D. and Morell P. (2001) Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain. J. Neurochem. 77, 10671076.DOI: 10.1046/j.1471-4159.2001.00310.x
  • Kagawa T., Oba A., Okumura S. and Ikenaka K. (1996) Localization of mRNA for UDP-galactose: ceramide galactosyltransferase in the brain during mouse development. Dev. Neurosci. 18, 309318.
  • Knobler R. L., Rodriguez M., Lampert P. W. and Oldstone M. B. (1983) Virologic models of chronic relapsing demyelinating disease. Acta Neuropathol. (Suppl.)(Berl.) 9, 3137.
  • Lee D. K., Lynch K. R., Nguyen T., Im D. S., Cheng R., Saldivia V. R., Liu Y., Liu I. S., Heng H. H., Seeman P., George S. R., O'Dowd B. F. and Marchese A. (2000) Cloning and characterization of additional members of the G protein-coupled receptor family. Biochim. Biophys. Acta 1490, 311323.
  • Ludwin S. K. (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab. Invest. 39, 597612.
  • Ludwin S. K. (1994) Central nervous system remyelination: studies in chronically damaged tissue. Ann. Neurol. 36, 143145.
  • Malik K. F., Jaffe H., Brady J. and Young W. S. 3rd (1997) The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U. Mol. Brain Res. 45, 99107.
  • Martin M., McFarland H. F. and McFarlin D. E. (1992) Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153187.
  • Mason J. L., Jones J., Takiike M., Morell P., Suzuki K. and Matsushima G. K. (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J. Neurosci. Res. 61, 251262.
  • Mason J. L., Langaman C., Morell P., Suzuki K. and Matsushima G. K. (2001) Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol. Appl. Neurobiol. 27, 5058.
  • Mathis C., Hindelang C., LeMeur M. and Borelli E. (2000) A transgenic mouse model for inducible and reversible dysmyelination. J. Neurosci. 20, 76987705.
  • Matsushima G. K. and Morell P. (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107116.
  • McMahon E. J., Cook D. N., Suzuki K. and Matsushima G. K. (2001) Absence of macrophage-inflammatory protein-1α delays central nervous system demyelination in the presence of an intact blood–brain barrier. J. Immunol. 167, 29642971.
  • Miller D. J., Asakura K. and Rodriguez M. (1996) Central nervous system remyelination clinical application of basic neuroscience principles. Brain. Pathol. 6, 331344.
  • Morell P. and Quarles R. H. (1999) Myelin formation, structure, and biochemistry, in Basic Neurochemistry, 6th edn (AlbersR. W., SiegelG. W., MolinoffP. and AgranoffB., eds), pp. 6993. Raven Press, New York.
  • Morell P., Barrett C. V., Mason J. L., Toews A. D., Hostettler J. D., Knapp G. W. and Matsushima G. K. (1998) Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol. Cell. Neurosci. 12, 220227.
  • Muse E. D., Jurevics H., Toews A. D., Matsushima G. K. and Morell P. (2001) Parameters related to lipid metabolism as markers of myelination in mouse brain. J. Neurochem. 76, 7786.
  • Norton W. T. (1977) Isolation and characterization of myelin, In Myelin (MorellP. ed.), pp. 161199. Plenum, New York.
  • Raine C. S. (1984) Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 50, 608635.
  • Schaeren-Wiemers N., Valenzuela D. M., Frank M. and Schwab M. E. (1995) Characterization of a rat gene, rMAL, encoding a protein with four hydrophobic domains in central and peripheral myelin. J. Neurosci. 8, 57535764.
  • Schreiber J., Enderich J., Sock E., Schmidt C., Richter-Landsberg C. and Wegner M. (1997) Redundancy of class III POU proteins in the oligodendrocyte lineage. J. Biol. Chem. 272, 3228632293.
  • Self A. J., Caron E., Paterson H. F. and Hall A. (2001) Analysis of R.-Ras signalling pathways. J. Cell Sci. 114, 13571366.
  • Sim F. J., Hinks G. L. and Franklin R. J. (2000) The re-expression of the homeodomain transcription factor Gtx during remyelination of experimentally induced demyelinating lesion in young and old rat brain. Neuroscience 100, 131139.
  • Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A. and Hilton D. J. (1997) A family of ctyokine-inducible inhibitors of signalling. Nature 387, 917921.
  • Stohlman S. A. and Hinton D. R. (2001) Viral induced demyelination. Brain Pathol. 11, 92106.
  • Suzuki K. and Kikkawa Y. (1969) Status spongiosus of CNS and hepaticchanges induced by cuprizone (bis-cyclohexanone oxalyldihydrazone). Am. J. Pathol. 54, 307325.
  • Szuchet S., Plachetzki D. C. and Eaton K. S. (2001) Oligodendrocyte transmembrane protein: a novel member of the glutamate-binding protein subfamily. Biochem. Biophys. Res. Commun. 283, 900907.
  • Toews A. D., Lee S., Popko B. and Morell P. (1990) Tellurium-induced neuropathy: a model for reversible reductions in myelin protein gene expression. J. Neurosci. Res. 26, 501507.
  • Venezie R. D., Toews A. D. and Morell P. (1995) Macrophage recruitment in different models of nerve injury: lysozyme as a marker for active phagocytosis. J. Neurosci. Res. 40, 99107.
  • Woodruff R. H. and Franklin R. J. (1999) Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complelment/anti-galactocerebroside: a comparative study. Glia 25, 216228.DOI: 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.3.CO;2-C
  • Yamamoto Y., Mizuno R., Nishimura T., Ogawa Y., Yoshikawa H., Fujimura H., Adachi E., Kishimoto T., Yanagihara T. and Sakoda S. (1994) Cloning and expression of myelin-associated oligodendrocytic basic protein. A novel basic protein constituting the central nervous system myelin. J. Biol. Chem. 269, 3172531730.
  • Ye P., Carson J. and D'Ercole A. J. (1995) Insulin-like growth factor-I influences the initiation of myelination: studies of the anterior commissure of transgenic mice. Neurosci. Lett. 201, 235238.